Eascra Biotech Funding & Investors

Eascra Biotech creates Janus base nanomaterials based on DNA nanotechnology that are highly effective and super biocompatible for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. Its three generations of DNA-inspired nanotubes are a low-cost, scalable alternative to existing options. Its Janus nanotechnologies can be tailored to improve the therapeutic efficacy of drug treatments for a variety of chronic conditions and medical needs.